SCHEMBL14798191

SCHEMBL14798191

O=CCCCCCCCCCCCC(O)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 3/20 0.57
FFAR1 O14842 1/20 0.57
TET2 Q6N021 3/20 0.43
KDM4A O75164 2/20 0.43
KDM4C Q9H3R0 2/20 0.43
KDM2A Q9Y2K7 2/20 0.43
TET3 O43151 1/20 0.43
TBXAS1 P24557 2/20 0.41
TSHR P16473 1/20 0.39
HIF1A Q16665 1/20 0.38
OR51E2 Q9H255 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
FAAH O00519 2/20 0.35
TRPV1 Q8NER1 1/20 0.35
USP2 O75604 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8152818 1.00 GPR84 (0.57) GPR84FFAR1TET2KDM4AKDM4C
SCHEMBL9477783 0.98 GPR84 (0.54) GPR84FFAR1TET2KDM4AKDM4C
SCHEMBL3374393 0.91 GPR84 (0.50) GPR84FFAR1TET2KDM4AKDM4C
SCHEMBL15308393 0.91 GPR84 (0.50) GPR84FFAR1TET2KDM4AKDM4C
SCHEMBL5696751 0.83 GPR84 (0.76) GPR84FFAR1TET2KDM4AKDM4C
SCHEMBL2371345 0.82 TSHR (0.42) GPR84FFAR1TBXAS1TSHRHIF1A
SCHEMBL8386657 0.81
SCHEMBL1366101 0.81 GPR84 (0.55) GPR84FFAR1TET2KDM4AKDM4C
SCHEMBL3794521 0.81 GPR84 (0.55) GPR84FFAR1TET2KDM4AKDM4C
SCHEMBL29466510 0.81 GPR84 (0.55) GPR84FFAR1TET2KDM4AKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8815549-B2 Ozonolysis of unsaturated fatty acids and derivatives thereof EVONIK DEGUSSA GMBH (DE) 2014-08-26 US disclosed
US-20130078685-A1 OZONOLYSIS OF UNSATURATED FATTY ACIDS AND DERIVATIVES THEREOF EVONIK DEGUSSA GMBH (DE) 2013-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130078685-A1 OZONOLYSIS OF UNSATURATED FATTY ACIDS AND DERIVATIVES THEREOF FASN, ALOX5, ALOX15 GPR84 1372/4885FFAR1 29/4885TET2 2239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.